Results 181 to 190 of about 1,742,061 (410)
Advanced Therapeutics, EarlyView.Emerging microphysiological systems reproduce the spatial, biochemical, and cellular complexity of the tumor microenvironment, surpassing 2D cultures and murine models. By integrating patient‐derived tumors, perfusable vasculature, and immune trafficking, these organ‐on‐chip platforms reveal mechanisms of immune evasion, predict therapeutic responses ...
Fabiana Moresi +5 more
wiley +1 more source
LEUKEMIA OF ADULT MICE CAUSED BY A TRANSMISSIBLE AGENT [PDF]
, 1957 Charlotte Friend
openalex +1 more source
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Science Translational Medicine, 2014 M. Davila +31 more
semanticscholar +1 more source
Genetic Engineering Methods in Primary T Cells
Advanced Therapeutics, EarlyView.Primary T cells can be engineered to confer them with novel therapeutic functions, allowing them to treat a variety of conditions. Genetic engineering can be either stable or transient, aiming to either express or inhibit a target gene. This review discusses the various genetic engineering tools available as well as their characteristics and ...
Anthony Youssef, Hui‐Shan Li
wiley +1 more source
CHANGES IN CIRCULATING LEUKOCYTES FOLLOWING THE ADMINISTRATION OF ADRENAL CORTEX EXTRACT (ACE) AND ADRENOCORTICOTROPIC HORMONE (ACTH) IN INFECTIOUS MONONUCLEOSIS AND CHRONIC LYMPHATIC LEUKEMIA [PDF]
, 1950 Richard H. Saunders, Elijah Adams
openalex +1 more source
Understanding miR‐200c: an Important Player in Resistance to Cancer Treatment
Advanced Therapeutics, EarlyView.How can one microRNA alter cancer's response to therapy? miR‐200c plays a central role in therapeutic resistance by modulating epithelial‐mesenchymal transition, apoptosis, cancer stemness features, and drug efflux. This review outlines the context‐dependent functions of miR‐200c in various cancers and highlights its potential as both a biomarker and a
Fatma Sanli, Omer Faruk Karatas
wiley +1 more source